939767 - Exelixis, Inc. - SEC Form 4 Insider Trading Screener

Services - Engineering, Accounting, Research, Management Services - Commercial Physical & Biological Research - EXEL (939767)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
100 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m
S29-1-1-0+0

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Share Price

Shares Traded

Shares Owned

Own chg

Value Traded

1d ret

1w ret

1m ret

6m ret

DM
2018-01-08
EXELGarber Alan MDirM - OptEx$7.97+15,00061,329+32%+$119,550
DM
2018-01-08
EXELGarber Alan MDirS - Sale+OE$30.30-15,00061,329-20%-$454,515
2017-11-15
EXELLamb PeterEVP, Scientific Strategy, CSOF - Tax$24.75-2,204142,799-2%-$54,549
2017-11-15
EXELSchwab GiselaPres Prod Dev, Med Aff, CMOF - Tax$24.75-2,609269,582-1%-$64,573
2017-11-15
EXELHaley Patrick J.SVP, CommercialF - Tax$24.75-3,739123,668-3%-$92,540
2017-11-15
EXELHessekiel JeffreyEVP, GCF - Tax$24.75-2,120317,256-1%-$52,470
2017-11-15
EXELSenner Christopher J.EVP, CFOF - Tax$24.75-2,762164,536-2%-$68,360
2017-11-15
EXELMorrissey MichaelPres, CEOF - Tax$24.75-8,347321,371-3%-$206,588
D
2017-10-03
EXELHaley Patrick J.SVP, CommercialA - Grant$0.00+50,000127,407+65%+$0
D
2017-10-03
EXELSchwab GiselaPres Prod Dev, Med Aff, CMOA - Grant$0.00+75,000272,191+38%+$0
D
2017-10-03
EXELLamb PeterEVP, Scientific Strategy, CSOA - Grant$0.00+55,000145,003+61%+$0
D
2017-10-03
EXELHessekiel JeffreyEVP, GCA - Grant$0.00+50,000318,260+19%+$0
D
2017-10-03
EXELSenner Christopher J.EVP, CFOA - Grant$0.00+62,500167,298+60%+$0
D
2017-10-03
EXELMorrissey MichaelPres, CEOA - Grant$0.00+80,000329,718+32%+$0
DM
2017-09-27
EXELHessekiel JeffreyEVP, GCM - OptEx$1.90+27,302268,260+11%+$51,874
DM
2017-09-27
EXELHessekiel JeffreyEVP, GCS - Sale+OE$24.28-27,302268,260-9%-$663,018
DM
2017-09-26
EXELSchwab GiselaPres Prod Dev, Med Aff, CMOM - OptEx$9.91+100,000197,191+103%+$991,000
DM
2017-09-26
EXELSchwab GiselaPres Prod Dev, Med Aff, CMOS - Sale+OE$23.79-100,000197,191-34%-$2,378,667
2017-09-22
EXELPapadopoulos SteliosDirS - Sale$25.40-10,0001,034,314-1%-$254,000
M
2017-09-18
EXELPapadopoulos SteliosDirS - Sale$27.68-200,0001,044,314-16%-$5,535,387
2017-09-14
EXELHaley Patrick J.SVP, CommercialS - Sale$27.21-60,64075,046-45%-$1,650,014
M
2017-09-12
EXELWillsey LanceDirS - Sale$26.88-100,000468,273-18%-$2,688,000
D
2017-09-12
EXELSenner Christopher J.EVP, CFOM - OptEx$3.66+100,000104,798>999%+$366,000
D
2017-09-12
EXELSenner Christopher J.EVP, CFOS - Sale+OE$26.79-100,000104,798-49%-$2,679,000
DM
2017-09-12
EXELMorrissey MichaelPres, CEOM - OptEx$1.70+300,000249,718-597%+$510,000
DM
2017-09-12
EXELMorrissey MichaelPres, CEOS - Sale+OE$26.90-300,000249,718-55%-$8,071,000
2017-05-30
EXELHaley Patrick J.SVP, CommercialS - Sale$18.46-5,000135,686-4%-$92,300
AD
2017-05-25
EXELPapadopoulos SteliosDirA - Grant$0.00+5,8431,244,3140%+$0
D
2017-05-25
EXELPoste GeorgeDirA - Grant$0.00+5,84383,398+8%+$0
D
2017-05-25
EXELWyszomierski Jack LDirA - Grant$0.00+5,84378,803+8%+$0
D
2017-05-25
EXELPapadopoulos SteliosDirA - Grant$0.00+5,8431,234,3140%+$0
D
2017-05-25
EXELMarchesi Vincent TDirA - Grant$0.00+5,843125,913+5%+$0
D
2017-05-15
EXELFeldbaum Carl BDirM - OptEx$8.75+19,00034,733+121%+$166,190
D
2017-05-15
EXELFeldbaum Carl BDirS - Sale+OE$21.58-32,98834,733-49%-$711,831
D
2017-05-15
EXELSchwab GiselaPres Prod Dev, Med Aff, CMOM - OptEx$5.04+12,501197,191+7%+$63,005
DM
2017-05-08
EXELMorrissey MichaelPres, CEOM - OptEx$1.88+211,300249,716+550%+$397,380-2
DM
2017-05-08
EXELMorrissey MichaelPres, CEOS - Sale+OE$21.87-211,300249,716-46%-$4,622,159-2
DM
2017-05-03
EXELMorrissey MichaelPres, CEOM - OptEx$1.90+259,149249,668-2733%+$492,383-10
DM
2017-05-03
EXELMorrissey MichaelPres, CEOS - Sale+OE$22.24-259,149249,668-51%-$5,762,838-10
D
2017-05-01
EXELSchwab GiselaPres Prod Dev, Med Aff, CMOM - OptEx$9.91+89,910184,690+95%+$891,008-2-3
D
2017-05-01
EXELSchwab GiselaPres Prod Dev, Med Aff, CMOS - Sale+OE$23.01-89,910184,690-33%-$2,068,519-2-3
D
2017-04-17
EXELSchwab GiselaPres Prod Dev, Med Aff, CMOM - OptEx$9.91+10,090182,329+6%+$99,992+1+2
D
2017-04-03
EXELMarchesi Vincent TDirM - OptEx$10.53+10,000120,070+9%+$105,300-4-5+6
D
2017-04-03
EXELMarchesi Vincent TDirS - Sale+OE$21.30-10,000120,070-8%-$213,000-4-5+6
D
2017-03-31
EXELWyszomierski Jack LDirM - OptEx$10.53+10,00072,960+16%+$105,300-2-6+7
D
2017-03-31
EXELWyszomierski Jack LDirS - Sale+OE$21.57-5,15072,960-7%-$111,086-2-6+7
D
2017-03-27
EXELCohen CharlesDirM - OptEx$10.53+10,000248,180+4%+$105,300-10+3
2017-03-27
EXELHessekiel JeffreyEVP, GCS - Sale$21.02-6,884267,946-3%-$144,702-10+3
D
2017-03-16
EXELHessekiel JeffreyEVP, GCG - Gift$0.00-3,000274,830-1%-$0+2+1+2
D
2017-03-22
EXELHessekiel JeffreyEVP, GCM - OptEx$1.70+55,000274,830+25%+$93,500+2+1+2
D
2017-03-22
EXELHessekiel JeffreyEVP, GCS - Sale+OE$20.54-23,787274,830-8%-$488,585+2+1+2
D
2017-03-20
EXELFeldbaum Carl BDirM - OptEx$10.53+10,00048,721+26%+$105,3000+4+3
D
2017-03-20
EXELFeldbaum Carl BDirS - Sale+OE$21.77-10,00048,721-17%-$217,7000+4+3
D
2017-03-20
EXELPapadopoulos SteliosDirM - OptEx$10.53+10,0001,238,471+1%+$105,3000+4+3
D
2017-03-20
EXELPapadopoulos SteliosDirS - Sale+OE$21.66-10,0001,238,471-1%-$216,6000+4+3
D
2017-03-15
EXELWillsey LanceDirM - OptEx$10.53+10,000568,273+2%+$105,3000-8-3
D
2017-03-15
EXELWillsey LanceDirS - Sale+OE$22.86-10,000568,273-2%-$228,6000-8-3
D
2017-03-15
EXELSchwab GiselaPres Prod Dev, Med Aff, CMOM - OptEx$6.20+50,007172,027+41%+$310,1790-8-3
D
2017-03-15
EXELSchwab GiselaPres Prod Dev, Med Aff, CMOS - Sale+OE$22.53-50,007172,027-23%-$1,126,6580-8-3
2017-03-13
EXELCohen CharlesDirS - Sale$21.82-10,000238,180-4%-$218,200+5+1-4
D
2017-03-10
EXELMarchesi Vincent TDirM - OptEx$3.13+40,000120,070+50%+$125,200+1+1-5
D
2017-03-10
EXELMarchesi Vincent TDirS - Sale+OE$21.98-40,000120,070-25%-$879,200+1+1-5
D
2017-03-03
EXELHessekiel JeffreyEVP, GCM - OptEx$7.27+100,000246,617+68%+$727,000-2-2-4
D
2017-03-03
EXELHessekiel JeffreyEVP, GCS - Sale+OE$23.04-100,000246,617-29%-$2,303,678-2-2-4
DM
2017-03-03
EXELMorrissey MichaelPres, CEOM - OptEx$9.91+200,000249,523+404%+$1,982,000-2-2-4
DM
2017-03-03
EXELMorrissey MichaelPres, CEOS - Sale+OE$22.72-200,000249,523-44%-$4,544,000-2-2-4
2017-03-03
EXELHaley Patrick J.SVP, CommercialS - Sale$23.04-2,500140,400-2%-$57,600-2-2-4
2017-03-03
EXELSenner Christopher J.EVP, CFOS - Sale$22.80-11,000102,181-10%-$250,800-2-5-6
D
2017-03-01
EXELLamb PeterEVP, Scientific Strategy, CSOM - OptEx$7.36+45,00089,728+101%+$331,350-2-5-6
D
2017-03-01
EXELLamb PeterEVP, Scientific Strategy, CSOS - Sale+OE$22.19-45,00089,728-33%-$998,550-2-5-6
DM
2017-03-01
EXELPoste GeorgeDirM - OptEx$5.20+76,25077,555>999%+$396,850-2-5-6
DM
2017-03-01
EXELPoste GeorgeDirS - Sale+OE$22.53-76,25077,555-50%-$1,718,185-2-5-6
D
2017-02-01
EXELLamb PeterEVP, Scientific Strategy, CSOM - OptEx$6.92+70,00089,680+356%+$484,300-1+12+13
D
2017-02-01
EXELLamb PeterEVP, Scientific Strategy, CSOS - Sale+OE$18.65-70,00089,680-44%-$1,305,500-1+12+13
D
2017-01-03
EXELLamb PeterEVP, Scientific Strategy, CSOM - OptEx$5.74+70,00089,624+357%+$401,800+2+21+34
D
2017-01-03
EXELLamb PeterEVP, Scientific Strategy, CSOS - Sale+OE$14.65-70,00089,624-44%-$1,025,636+2+21+34
D
2016-12-16
EXELFeldbaum Carl BDirM - OptEx$10.41+25,00048,721+105%+$260,250-3-11+7
D
2016-12-16
EXELFeldbaum Carl BDirS - Sale+OE$17.03-25,00048,721-34%-$425,750-3-11+7
D
2016-12-09
EXELGarber Alan MDirM - OptEx$10.53+10,00061,329+19%+$105,300-2-1+12
D
2016-12-09
EXELGarber Alan MDirS - Sale+OE$16.90-7,83261,329-11%-$132,361-2-1+12
DM
2016-12-05
EXELScangos George ADirM - OptEx$8.99+358,3321,487,243+32%+$3,221,405+2-2-7
DM
2016-12-05
EXELScangos George ADirS - Sale+OE$17.81-204,8941,487,243-12%-$3,649,178+2-2-7
D
2016-12-01
EXELLamb PeterEVP, Scientific Strategy, CSOM - OptEx$5.27+70,00089,624+357%+$368,800+3-3-16
D
2016-12-01
EXELLamb PeterEVP, Scientific Strategy, CSOS - Sale+OE$16.66-70,00089,624-44%-$1,166,200+3-3-16
D
2016-12-01
EXELSchwab GiselaPres Prod Dev, Med Aff, CMOM - OptEx$8.99+22,000171,859+15%+$197,780+3-3-16
D
2016-12-01
EXELSchwab GiselaPres Prod Dev, Med Aff, CMOS - Sale+OE$16.73-22,000171,859-11%-$368,060+3-3-16
AD
2016-09-22
EXELSenner Christopher J.EVP, CFOA - Grant$0.00+20,000127,636+19%+$0+3+3-10
AD
2016-07-15
EXELSenner Christopher J.EVP, CFOF - Tax$8.44-46,751127,636-27%-$394,578+3+3-10
D
2016-11-09
EXELMorrissey MichaelPres, CEOM - OptEx$8.99+200,000251,329+390%+$1,798,000-1+1-4
D
2016-11-09
EXELMorrissey MichaelPres, CEOS - Sale+OE$15.00-200,000251,329-44%-$3,000,000-1+1-4
D
2016-11-09
EXELSchwab GiselaPres Prod Dev, Med Aff, CMOM - OptEx$8.99+22,000171,859+15%+$197,780-1+1-4
D
2016-11-09
EXELSchwab GiselaPres Prod Dev, Med Aff, CMOS - Sale+OE$15.00-22,000171,859-11%-$330,000-1+1-4
D
2016-11-09
EXELLamb PeterEVP, Scientific Strategy, CSOM - OptEx$5.17+70,00089,624+357%+$362,000-1+1-4
D
2016-11-09
EXELLamb PeterEVP, Scientific Strategy, CSOS - Sale+OE$13.15-70,00089,624-44%-$920,500-1+1-4
D
2016-09-22
EXELHessekiel JeffreyEVP, GCA - Grant$0.00+16,250246,617+7%+$0+1-17-27+41
D
2016-09-22
EXELLamb PeterEVP, Scientific Strategy, CSOA - Grant$0.00+16,25089,624+22%+$0+1-17-27+41
D
2016-09-22
EXELSchwab GiselaPres Prod Dev, Med Aff, CMOA - Grant$0.00+20,000170,247+13%+$0+1-17-27+41
D
2016-09-22
EXELSenner Christopher J.EVP, CFOA - Grant$0.00+20,000154,387+15%+$0+1-17-27+41
D
2016-09-26
EXELMorrissey MichaelPres, CEOA - Grant$0.00+60,000251,329+31%+$0+1-17-27+41
D
2016-09-22
EXELSmith JulieDirA - Grant$0.00+763763New+$0+1-17-27+41

Real-time CSV? Options? Alerts? Contact us!
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top